NEUROGENE INC. (NGNE)
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
Streamex Corp. Announces First Yield Dividend Distribution for GLDY
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress
Valvoline Inc. Named Children’s Miracle Network’s 2026 U.S. Corporate Partner of the Year
SL Green Partners with Hyundai Motor Group on Newly Developed 15 Laight Street
Watsco To Acquire Jackson Supply Company
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution